drugset / Trial / NCT01144897
PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy
NaSingle-groupOpen-labelDiagnostic
Summary
One purpose of this research study is to examine if a special type of imaging test, a positron emission tomography (PET) scan using the radioactive material \[C-11\] acetate, will be helpful in detecting prostate cancer lesions in subjects with castrate-resistant prostate cancer (CRPC). This PET scan will be combined with a computed tomography (CT) scan taken during the same imaging session. The other purpose of the PET-CT scan using \[C-11\] acetate (PET Acetate Scan) is to assist in identifying who is responding to the treatment (docetaxel chemotherapy).
Timeline
- Start
- 2010-05
- Primary completion
- 2011-11
- Completion
- 2018-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbon-11 labeled Acetate | Diagnostic / imaging agent | — | — |